Advanced nanoscale delivery systems for mRNA-based vaccines

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Nanomedicine and Drug Delivery Systems
• Vaccinology and Immunology

Background:

• Messenger RNA (mRNA) vaccine efficacy is critically dependent on efficient delivery to target cells.
• Various nanoscale vaccine delivery systems (VDSs) are under investigation, including lipid nanoparticles (LNPs), liposomes, polymeric nanoparticles, and viral vectors.
• Lipid nanoparticles (LNPs) are highly effective at encapsulating and protecting mRNA payloads.

Purpose of the Study:

• To review recent advancements in delivery mechanisms for self-amplifying RNA (saRNA) vaccines.
• To highlight innovative nanoscale delivery systems for mRNA and saRNA vaccines.
• To emphasize improvements in the efficacy and safety of RNA-based vaccines through optimized delivery.

Main Methods:

• Comprehensive literature review of recent studies on nanoscale vaccine delivery systems (VDSs).
• Analysis of different VDS types, including lipid nanoparticles (LNPs), liposomes, and polymeric nanoparticles.
• Focus on engineering strategies to enhance mRNA/saRNA stability, cellular uptake, and immune response.

Main Results:

• Nanoscale VDSs, particularly LNPs, demonstrate significant potential for protecting and delivering mRNA/saRNA.
• Engineered VDSs can be tailored to improve stability, cellular targeting, and overall vaccine performance.
• The selection of an appropriate VDS is crucial and depends on vaccine specifics and desired outcomes.

Conclusions:

• Advanced nanoscale delivery systems are essential for the success of mRNA and saRNA vaccines.
• Continued research into VDSs, especially LNPs, is vital for developing safer and more effective RNA vaccines.
• Optimized delivery strategies hold the key to unlocking the full therapeutic potential of RNA-based immunization.